{
    "abstract": "The modular binding sites on the influenza A(H3N2) hemagglutinin protein are under significant pressure to acquire mutations in order to evade human antibody recognition. Analysis of these hemagglutinin epitopes in the strains circulating during 2017/18 and early 2018/19 identified the emergence of a new antigenic cluster that has grown from 4% of circulating strains to 11%. We regressed our module-based antigenic distance, pepitope, with A(H3N2) vaccine effectiveness from recent studies conducted by the US Centers for Disease Control and Prevention (r2 = 0.92), and we used this to estimate that the 2018/19 vaccines will protect against most circulating A(H3N2) strains. The pEpitope model is useful for A(H3N2) influenza vaccine virus selection and development, and it has the potential to aid national or regional regulatory authorities in making geographically localized decisions.",
    "bib_entries": {
        "b0005": {
            "authors": [
                {
                    "first": "Velislava N.",
                    "initial": "V.N.",
                    "last": "Petrova"
                },
                {
                    "first": "Colin A.",
                    "initial": "C.A.",
                    "last": "Russell"
                }
            ],
            "doi": "10.1038/nrmicro.2017.118",
            "firstpage": "47",
            "issn": "17401526",
            "lastpage": "60",
            "pmid": "29081496",
            "pub_year": 2018,
            "title": "The evolution of seasonal influenza viruses",
            "volume": "16"
        },
        "b0010": {
            "authors": [
                {
                    "first": "Enrique T.",
                    "initial": "E.T.",
                    "last": "Mu\u00f1oz"
                },
                {
                    "first": "Michael W.",
                    "initial": "M.W.",
                    "last": "Deem"
                }
            ],
            "doi": "10.1016/j.vaccine.2004.08.028",
            "firstpage": "1144",
            "issn": "0264410X",
            "lastpage": "1148",
            "pmid": "15629357",
            "pub_year": 2005,
            "title": "Epitope analysis for influenza vaccine design",
            "volume": "23"
        },
        "b0015": {
            "authors": [
                {
                    "first": "William",
                    "initial": "W.",
                    "last": "Humphrey"
                },
                {
                    "first": "Andrew",
                    "initial": "A.",
                    "last": "Dalke"
                },
                {
                    "first": "Klaus",
                    "initial": "K.",
                    "last": "Schulten"
                }
            ],
            "doi": "10.1016/0263-7855(96)00018-5",
            "firstpage": "33",
            "issn": "02637855",
            "lastpage": "38",
            "pmid": "8744570",
            "pub_year": 1996,
            "title": "VMD: Visual molecular dynamics",
            "volume": "14"
        },
        "b0020": {
            "authors": [
                {
                    "first": "Derek J.",
                    "initial": "D.J.",
                    "last": "Smith"
                },
                {
                    "first": "Alan S.",
                    "initial": "A.S.",
                    "last": "Lapedes"
                },
                {
                    "first": "Jan C.",
                    "initial": "J.C.",
                    "last": "De Jong"
                },
                {
                    "first": "Theo M.",
                    "initial": "T.M.",
                    "last": "Bestebroer"
                },
                {
                    "first": "Guus F.",
                    "initial": "G.F.",
                    "last": "Rimmelzwaan"
                },
                {
                    "first": "Albert D.M.E.",
                    "initial": "A.D.M.E.",
                    "last": "Osterhaus"
                },
                {
                    "first": "Ron A.M.",
                    "initial": "R.A.M.",
                    "last": "Fouchier"
                }
            ],
            "doi": "10.1126/science.1097211",
            "firstpage": "371",
            "issn": "00368075",
            "lastpage": "376",
            "pmid": "15218094",
            "pub_year": 2004,
            "title": "Mapping the antigenic and genetic evolution of influenza virus",
            "volume": "305"
        },
        "b0025": {
            "authors": [
                {
                    "first": "Jiankui",
                    "initial": "J.",
                    "last": "He"
                },
                {
                    "first": "Michael W.",
                    "initial": "M.W.",
                    "last": "Deem"
                }
            ],
            "doi": "10.1093/protein/gzq078",
            "firstpage": "935",
            "issn": "17410126",
            "lastpage": "946",
            "pmid": "21036781",
            "pub_year": 2010,
            "title": "Low-dimensional clustering detects incipient dominant influenza strain clusters",
            "volume": "23"
        },
        "b0030": {
            "authors": [
                {
                    "first": "Alan",
                    "initial": "A.",
                    "last": "Hampson"
                },
                {
                    "first": "Ian",
                    "initial": "I.",
                    "last": "Barr"
                },
                {
                    "first": "Nancy",
                    "initial": "N.",
                    "last": "Cox"
                },
                {
                    "first": "Ruben O.",
                    "initial": "R.O.",
                    "last": "Donis"
                },
                {
                    "first": "Hirve",
                    "initial": "H.",
                    "last": "Siddhivinayak"
                },
                {
                    "first": "Daniel",
                    "initial": "D.",
                    "last": "Jernigan"
                },
                {
                    "first": "Jacqueline",
                    "initial": "J.",
                    "last": "Katz"
                },
                {
                    "first": "John",
                    "initial": "J.",
                    "last": "McCauley"
                },
                {
                    "first": "Fernando",
                    "initial": "F.",
                    "last": "Motta"
                },
                {
                    "first": "Takato",
                    "initial": "T.",
                    "last": "Odagiri"
                },
                {
                    "first": "John S.",
                    "initial": "J.S.",
                    "last": "Tam"
                },
                {
                    "first": "Anthony",
                    "initial": "A.",
                    "last": "Waddell"
                },
                {
                    "first": "Richard",
                    "initial": "R.",
                    "last": "Webby"
                },
                {
                    "first": "Thedi",
                    "initial": "T.",
                    "last": "Ziegler"
                },
                {
                    "first": "Wenqing",
                    "initial": "W.",
                    "last": "Zhang"
                }
            ],
            "doi": "10.1016/j.vaccine.2017.01.018",
            "firstpage": "1104",
            "issn": "0264410X",
            "lastpage": "1109",
            "pmid": "28131392",
            "pub_year": 2017,
            "title": "Improving the selection and development of influenza vaccine viruses \u2013 Report of a WHO informal consultation on improving influenza vaccine virus selection, Hong Kong SAR, China, 18\u201320 November 2015",
            "volume": "35"
        },
        "b0035": {
            "authors": [
                {
                    "first": "Melia E.",
                    "initial": "M.E.",
                    "last": "Bonomo"
                },
                {
                    "first": "Michael W.",
                    "initial": "M.W.",
                    "last": "Deem"
                }
            ],
            "doi": "10.1093/cid/ciy323",
            "firstpage": "1129",
            "issn": "10584838",
            "lastpage": "1131",
            "pmid": "29672670",
            "pub_year": 2018,
            "title": "Predicting Influenza H3N2 Vaccine Efficacy from Evolution of the Dominant Epitope",
            "volume": "67"
        },
        "b0040": {
            "authors": [
                {
                    "first": "Jun",
                    "initial": "J.",
                    "last": "Sun"
                },
                {
                    "first": "David J.",
                    "initial": "D.J.",
                    "last": "Earl"
                },
                {
                    "first": "Michael W.",
                    "initial": "M.W.",
                    "last": "Deem"
                }
            ],
            "doi": "10.1142/S0217984906010494",
            "firstpage": "63",
            "issn": "02179849",
            "lastpage": "95",
            "pub_year": 2006,
            "title": "Localization and glassy dynamics in the immune system",
            "volume": "20"
        },
        "b0045": {
            "authors": [
                {
                    "first": "Yidan",
                    "initial": "Y.",
                    "last": "Pan"
                },
                {
                    "first": "Michael W.",
                    "initial": "M.W.",
                    "last": "Deem"
                }
            ],
            "doi": "10.1016/j.vaccine.2016.07.015",
            "firstpage": "4610",
            "issn": "0264410X",
            "lastpage": "4617",
            "pmid": "27473305",
            "pub_year": 2016,
            "title": "Prediction of influenza B vaccine effectiveness from sequence data",
            "volume": "34"
        },
        "b0050": {
            "authors": [
                {
                    "first": "Keyao",
                    "initial": "K.",
                    "last": "Pan"
                },
                {
                    "first": "Krystina C.",
                    "initial": "K.C.",
                    "last": "Subieta"
                },
                {
                    "first": "Michael W.",
                    "initial": "M.W.",
                    "last": "Deem"
                }
            ],
            "doi": "10.1093/protein/gzq105",
            "firstpage": "291",
            "issn": "17410126",
            "lastpage": "299",
            "pmid": "21123189",
            "pub_year": 2011,
            "title": "A novel sequence-based antigenic distance measure for H1N1, with application to vaccine effectiveness and the selection of vaccine strains",
            "volume": "24"
        },
        "b0055": {
            "authors": [
                {
                    "first": "Geoffrey A.",
                    "initial": "G.A.",
                    "last": "Weinberg"
                },
                {
                    "first": "Peter G.",
                    "initial": "P.G.",
                    "last": "Szilagyi"
                }
            ],
            "doi": "10.1086/652404",
            "firstpage": "1607",
            "issn": "00221899",
            "lastpage": "1610",
            "pmid": "20402594",
            "pub_year": 2010,
            "title": "Vaccine epidemiology: Efficacy, effectiveness, and the translational research roadmap",
            "volume": "201"
        },
        "b0060": {
            "authors": [
                {
                    "first": "Yuelong",
                    "initial": "Y.",
                    "last": "Shu"
                },
                {
                    "first": "John",
                    "initial": "J.",
                    "last": "McCauley"
                }
            ],
            "doi": "10.2807/1560-7917.ES.2017.22.13.30494",
            "issn": "1025496X",
            "pmid": "28382917",
            "pub_year": 2017,
            "title": "GISAID: Global initiative on sharing all influenza data \u2013 from vision to reality",
            "volume": "22"
        },
        "b0065": null,
        "b0095": null,
        "b0100": {
            "authors": [
                {
                    "first": "Seth J.",
                    "initial": "S.J.",
                    "last": "Zost"
                },
                {
                    "first": "Kaela",
                    "initial": "K.",
                    "last": "Parkhouse"
                },
                {
                    "first": "Megan E.",
                    "initial": "M.E.",
                    "last": "Gumina"
                },
                {
                    "first": "Kangchon",
                    "initial": "K.",
                    "last": "Kim"
                },
                {
                    "first": "Sebastian Diaz",
                    "initial": "S.D.",
                    "last": "Perez"
                },
                {
                    "first": "Patrick C.",
                    "initial": "P.C.",
                    "last": "Wilson"
                },
                {
                    "first": "John J.",
                    "initial": "J.J.",
                    "last": "Treanor"
                },
                {
                    "first": "Andrea J.",
                    "initial": "A.J.",
                    "last": "Sant"
                },
                {
                    "first": "Sarah",
                    "initial": "S.",
                    "last": "Cobey"
                },
                {
                    "first": "Scott E.",
                    "initial": "S.E.",
                    "last": "Hensley"
                }
            ],
            "doi": "10.1073/pnas.1712377114",
            "firstpage": "12578",
            "issn": "00278424",
            "lastpage": "12583",
            "pmid": "29109276",
            "pub_year": 2017,
            "title": "Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains",
            "volume": "114"
        },
        "b0105": {
            "authors": [
                {
                    "first": "Hang",
                    "initial": "H.",
                    "last": "Xie"
                },
                {
                    "first": "Lei",
                    "initial": "L.",
                    "last": "Li"
                },
                {
                    "first": "Zhiping",
                    "initial": "Z.",
                    "last": "Ye"
                },
                {
                    "first": "Xing",
                    "initial": "X.",
                    "last": "Li"
                },
                {
                    "first": "Ewan P.",
                    "initial": "E.P.",
                    "last": "Plant"
                },
                {
                    "first": "Olga",
                    "initial": "O.",
                    "last": "Zoueva"
                },
                {
                    "first": "Yangqing",
                    "initial": "Y.",
                    "last": "Zhao"
                },
                {
                    "first": "Xianghong",
                    "initial": "X.",
                    "last": "Jing"
                },
                {
                    "first": "Zhengshi",
                    "initial": "Z.",
                    "last": "Lin"
                },
                {
                    "first": "Toshiaki",
                    "initial": "T.",
                    "last": "Kawano"
                },
                {
                    "first": "Meng Jung",
                    "initial": "M.J.",
                    "last": "Chiang"
                },
                {
                    "first": "Courtney L.",
                    "initial": "C.L.",
                    "last": "Finch"
                },
                {
                    "first": "Martina",
                    "initial": "M.",
                    "last": "Kosikova"
                },
                {
                    "first": "Anding",
                    "initial": "A.",
                    "last": "Zhang"
                },
                {
                    "first": "Yanhong",
                    "initial": "Y.",
                    "last": "Zhu"
                },
                {
                    "first": "Xiu Feng",
                    "initial": "X.F.",
                    "last": "Wan"
                }
            ],
            "doi": "10.1093/cid/cix269",
            "firstpage": "259",
            "issn": "10584838",
            "lastpage": "267",
            "pmid": "28369230",
            "pub_year": 2017,
            "title": "Differential Effects of Prior Influenza Exposures on H3N2 Cross-reactivity of Human Postvaccination Sera",
            "volume": "65"
        },
        "b0110": null,
        "b0115": {
            "authors": [
                {
                    "first": "Joshua D.",
                    "initial": "J.D.",
                    "last": "Doyle"
                },
                {
                    "first": "Jessie R.",
                    "initial": "J.R.",
                    "last": "Chung"
                },
                {
                    "first": "Sara S.",
                    "initial": "S.S.",
                    "last": "Kim"
                },
                {
                    "first": "Manjusha",
                    "initial": "M.",
                    "last": "Gaglani"
                },
                {
                    "first": "Chandni",
                    "initial": "C.",
                    "last": "Raiyani"
                },
                {
                    "first": "Richard K.",
                    "initial": "R.K.",
                    "last": "Zimmerman"
                },
                {
                    "first": "Mary Patricia",
                    "initial": "M.P.",
                    "last": "Nowalk"
                },
                {
                    "first": "Michael L.",
                    "initial": "M.L.",
                    "last": "Jackson"
                },
                {
                    "first": "Lisa A.",
                    "initial": "L.A.",
                    "last": "Jackson"
                },
                {
                    "first": "Arnold S.",
                    "initial": "A.S.",
                    "last": "Monto"
                },
                {
                    "first": "Emily T.",
                    "initial": "E.T.",
                    "last": "Martin"
                },
                {
                    "first": "Edward A.",
                    "initial": "E.A.",
                    "last": "Belongia"
                },
                {
                    "first": "Huong Q.",
                    "initial": "H.Q.",
                    "last": "McLean"
                },
                {
                    "first": "Angie",
                    "initial": "A.",
                    "last": "Foust"
                },
                {
                    "first": "Wendy",
                    "initial": "W.",
                    "last": "Sessions"
                },
                {
                    "first": "La Shondra",
                    "initial": "L.S.",
                    "last": "Berman"
                },
                {
                    "first": "Rebecca J.",
                    "initial": "R.J.",
                    "last": "Garten"
                },
                {
                    "first": "John R.",
                    "initial": "J.R.",
                    "last": "Barnes"
                },
                {
                    "first": "David E.",
                    "initial": "D.E.",
                    "last": "Wentworth"
                },
                {
                    "first": "Alicia M.",
                    "initial": "A.M.",
                    "last": "Fry"
                },
                {
                    "first": "Manish M.",
                    "initial": "M.M.",
                    "last": "Patel"
                },
                {
                    "first": "Brendan",
                    "initial": "B.",
                    "last": "Flannery"
                }
            ],
            "doi": "10.15585/mmwr.mm6806a2",
            "firstpage": "135",
            "issn": "01492195",
            "lastpage": "139",
            "pmid": "30763298",
            "pub_year": 2019,
            "title": "Interim estimates of 2018-19 seasonal influenza vaccine effectiveness - United States, February 2019",
            "volume": "68"
        }
    },
    "body_text": [
        {
            "endOffset": 29709,
            "parents": [],
            "secId": "s0045",
            "sentence": "Our present study focuses on the effectiveness of the A(H3N2) vaccine component and therefore cannot estimate the overall performance of the 2018/19 vaccine.",
            "startOffset": 29552,
            "title": "Limitations"
        },
        {
            "endOffset": 29902,
            "parents": [],
            "refoffsets": {
                "b0115": {
                    "endOffset": 29901,
                    "startOffset": 29897
                }
            },
            "secId": "s0045",
            "sentence": "Interim estimates from test-negative design case-control studies conducted by the CDC US Flu VE Network have shown that A(H1N1) has been the predominant subtype during the 2018/19 season [23].",
            "startOffset": 29710,
            "title": "Limitations"
        },
        {
            "endOffset": 18129,
            "parents": [],
            "refoffsets": {
                "b0030": {
                    "endOffset": 18128,
                    "startOffset": 18123
                },
                "b0035": {
                    "endOffset": 18128,
                    "startOffset": 18123
                }
            },
            "secId": "s0005",
            "sentence": "The virus may additionally acquire binding site mutations during the vaccine manufacturing process, e.g., when it is isolated in chicken eggs [6,7].",
            "startOffset": 17981,
            "title": "Introduction"
        },
        {
            "endOffset": 30469,
            "parents": [],
            "secId": "s0050",
            "sentence": "This module-based antigenic distance aids in the selection of specimen strains for the vaccine that are predicted to effectively prime human antibodies against the majority of circulating strains.",
            "startOffset": 30273,
            "title": "Conclusions"
        },
        {
            "endOffset": 28218,
            "parents": [],
            "secId": "s0040",
            "sentence": "The r2 = 0.92 on the US Flu VE Network dataset suggested the pEpitope model has heightened predictability when it is calibrated using studies that are geographically localized and have high consistency in data collection and clinical procedures.",
            "startOffset": 27973,
            "title": "Discussion"
        },
        {
            "endOffset": 24300,
            "parents": [
                {
                    "id": "s0025",
                    "title": "Results"
                }
            ],
            "secId": "s0030",
            "sentence": "The A/Paris/2511/2018 strain representative of this distant cluster is homologous to A/Arizona/36/2018 in the epitope regions.",
            "startOffset": 24174,
            "title": "Emergence of an A(H3N2) quasispecies during the 2018/19 season"
        },
        {
            "endOffset": 32702,
            "parents": [],
            "secId": "s0055",
            "sentence": "This work was supported by the Center for Theoretical Biological Physics at Rice University, Houston TX [National Science Foundation, PHY 1427654] and the Welch Foundation [C-1917-20170325].",
            "startOffset": 32512,
            "title": "Funding"
        },
        {
            "endOffset": 17775,
            "parents": [],
            "refoffsets": {
                "b0020": {
                    "endOffset": 17737,
                    "startOffset": 17734
                },
                "b0025": {
                    "endOffset": 17774,
                    "startOffset": 17771
                }
            },
            "secId": "s0005",
            "sentence": "The accumulation of mutations leads HA to evolve as quasispecies clusters in ferret-based antigenic distance space [4] and in amino acid sequence space [5].",
            "startOffset": 17619,
            "title": "Introduction"
        },
        {
            "endOffset": 32833,
            "parents": [],
            "secId": "s0060",
            "sentence": "MEB, RYK, and MWD interpreted data.",
            "startOffset": 32798,
            "title": "Author contributions"
        },
        {
            "endOffset": 29552,
            "parents": [],
            "secId": "s0045",
            "sentence": "Additional work is needed to assess the potential benefits of incorporating these factors into the pepitope measure of antigenic distance.",
            "startOffset": 29414,
            "title": "Limitations"
        },
        {
            "endOffset": 17618,
            "parents": [],
            "refoffsets": {
                "b0005": {
                    "endOffset": 17617,
                    "startOffset": 17614
                }
            },
            "secId": "s0005",
            "sentence": "In a gradual process referred to as \u201cantigenic drift,\u201d there is selection for mutations in the epitopes that allow the influenza virus to evade antibody recognition [1].",
            "startOffset": 17449,
            "title": "Introduction"
        },
        {
            "endOffset": 31252,
            "parents": [],
            "refoffsets": {
                "b0035": {
                    "endOffset": 31251,
                    "startOffset": 31248
                }
            },
            "secId": "s0050",
            "sentence": "There have been several seasons in which the specimen selected for the vaccine was well-chosen to match dominant circulating strains, however the egg-isolated CVV contained critical antigenic changes that ultimately lowered vaccine efficacy [7].",
            "startOffset": 31007,
            "title": "Conclusions"
        },
        {
            "endOffset": 32770,
            "parents": [],
            "secId": "s0060",
            "sentence": "MWD conceived the project and provided guidance.",
            "startOffset": 32722,
            "title": "Author contributions"
        },
        {
            "endOffset": 23941,
            "parents": [
                {
                    "id": "s0025",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0025": {
                    "endOffset": 23940,
                    "startOffset": 23937
                }
            },
            "secId": "s0030",
            "sentence": "The A/Arizona/36/2018 strain representative of the distant cluster had a pepitope of 0.191 from both of the CVV strains, approximately where vaccine effectiveness has gone to zero in the past [5].",
            "startOffset": 23745,
            "title": "Emergence of an A(H3N2) quasispecies during the 2018/19 season"
        },
        {
            "endOffset": 31310,
            "parents": [],
            "secId": "s0050",
            "sentence": "The pEpitope model successfully identified these changes.",
            "startOffset": 31253,
            "title": "Conclusions"
        },
        {
            "endOffset": 24573,
            "parents": [
                {
                    "id": "s0025",
                    "title": "Results"
                }
            ],
            "secId": "s0030",
            "sentence": "Multidimensional scaling of the A/Arizona/36/2018 and A/Paris/2511/2018 clusters reveals that these variants are part of the same viral quasispecies (Supplementary Fig. 1).",
            "startOffset": 24401,
            "title": "Emergence of an A(H3N2) quasispecies during the 2018/19 season"
        },
        {
            "endOffset": 24039,
            "parents": [
                {
                    "id": "s0025",
                    "title": "Results"
                }
            ],
            "secId": "s0030",
            "sentence": "The A/Arizona/36/2018 cluster contained 174 strains, or 3.6% of all those circulating in 2017/18.",
            "startOffset": 23942,
            "title": "Emergence of an A(H3N2) quasispecies during the 2018/19 season"
        },
        {
            "endOffset": 17374,
            "parents": [],
            "refoffsets": {
                "b0005": {
                    "endOffset": 17363,
                    "startOffset": 17358
                },
                "b0010": {
                    "endOffset": 17363,
                    "startOffset": 17358
                }
            },
            "secId": "s0005",
            "sentence": "Of the two influenza surface proteins that the human immune system recognizes, i.e., hemagglutinin (HA) and neuraminidase, there is significant pressure on HA to evolve since most antibodies recognize the virus through five epitopes on its globular head [1,2] (Fig. 1A).",
            "startOffset": 17104,
            "title": "Introduction"
        },
        {
            "endOffset": 25953,
            "parents": [
                {
                    "id": "s0025",
                    "title": "Results"
                }
            ],
            "secId": "s0035",
            "sentence": "Based on the higher average pepitope distances against strains circulating during the early 2018/19 season, the predicted effectiveness has gone down to 21 \u00b1 11% for the egg-based CVV and 25 \u00b1 11% for the cell-based CVV.",
            "startOffset": 25733,
            "title": "Prediction of effectiveness for the 2018/19 A(H3N2) vaccines"
        },
        {
            "endOffset": 33009,
            "parents": [],
            "secId": "s0060",
            "sentence": "MEB designed figures.",
            "startOffset": 32988,
            "title": "Author contributions"
        },
        {
            "endOffset": 27721,
            "parents": [],
            "refoffsets": {
                "b0030": {
                    "endOffset": 27720,
                    "startOffset": 27717
                }
            },
            "secId": "s0040",
            "sentence": "The vaccine manufacture and administration protocols as well as the diagnosis methodologies of influenza versus influenza-like illness during clinical studies have strengthened over time [6].",
            "startOffset": 27530,
            "title": "Discussion"
        },
        {
            "endOffset": 29169,
            "parents": [],
            "refoffsets": {
                "b0105": {
                    "endOffset": 29168,
                    "startOffset": 29164
                }
            },
            "secId": "s0045",
            "sentence": "For one, there is evidence to suggest that prior influenza vaccinations have differential effects on the antigenic distance seen by the human immune system to new infections [21].",
            "startOffset": 28990,
            "title": "Limitations"
        },
        {
            "endOffset": 27074,
            "parents": [],
            "refoffsets": {
                "b0025": {
                    "endOffset": 27073,
                    "startOffset": 27070
                }
            },
            "secId": "s0040",
            "sentence": "This is in agreement with the distance at which we have seen new antigenic quasispecies evolving in clusters historically [5].",
            "startOffset": 26948,
            "title": "Discussion"
        },
        {
            "endOffset": 31441,
            "parents": [],
            "secId": "s0050",
            "sentence": "Finally, the pEpitope model contributes to health policy and vaccine planning regarding localized geographical vaccination choices.",
            "startOffset": 31310,
            "title": "Conclusions"
        },
        {
            "endOffset": 28989,
            "parents": [],
            "secId": "s0045",
            "sentence": "There is a complexity of factors that may influence antibody recognition of influenza HA antigens.",
            "startOffset": 28891,
            "title": "Limitations"
        },
        {
            "endOffset": 26536,
            "parents": [],
            "secId": "s0040",
            "sentence": "The pEpitope model was readily able to estimate the antigenic distance either between individual CVV and dominant circulating strain pairs, or between thousands of influenza strains.",
            "startOffset": 26354,
            "title": "Discussion"
        },
        {
            "endOffset": 30822,
            "parents": [],
            "refoffsets": {
                "b0020": {
                    "endOffset": 30627,
                    "startOffset": 30624
                },
                "b0030": {
                    "endOffset": 30551,
                    "startOffset": 30548
                }
            },
            "secId": "s0050",
            "sentence": "While there are existing forecasting models for the dominant seasonal strains [6] and the emergence of quasispecies from antigenic drift in animal models [4], pEpitope adds an additional dimension to increase the likelihood that the chosen specimen minimizes antigenic distance within the dominant cluster to which the human immune system is sensitive.",
            "startOffset": 30470,
            "title": "Conclusions"
        },
        {
            "endOffset": 27291,
            "parents": [],
            "secId": "s0040",
            "sentence": "There is likely to be increased selection for A/Arizona/36/2018-like strains if the A(H3N2) vaccine component remains at a pepitope distance > 0.19, given the lack of protection against strains that are this distant.",
            "startOffset": 27075,
            "title": "Discussion"
        },
        {
            "endOffset": 33052,
            "parents": [],
            "secId": "s0060",
            "sentence": "All authors approved the final manuscript.",
            "startOffset": 33010,
            "title": "Author contributions"
        },
        {
            "endOffset": 26343,
            "parents": [
                {
                    "id": "s0025",
                    "title": "Results"
                }
            ],
            "secId": "s0035",
            "sentence": "However, the 2018/19 vaccines are anticipated to perform better against the majority of 2018/19 A(H3N2) strains, which are A/California/77/2018-like, at 34 \u00b1 10% and 31 \u00b1 10% for the egg and cell CVVs, respectively.",
            "startOffset": 26128,
            "title": "Prediction of effectiveness for the 2018/19 A(H3N2) vaccines"
        },
        {
            "endOffset": 31646,
            "parents": [],
            "secId": "s0050",
            "sentence": "The national or regional regulatory authorities and control laboratories that determine the vaccine composition for each country could utilize the pEpitope model when choosing from the WHO\u2019s list of CVVs.",
            "startOffset": 31442,
            "title": "Conclusions"
        },
        {
            "endOffset": 26947,
            "parents": [],
            "secId": "s0040",
            "sentence": "The analysis also suggested a small cluster of strains that are antigenically-like A/Arizona/36/2018 is emerging at a pepitope > 0.19 from the current CVVs, beyond the limit for effective immune protection.",
            "startOffset": 26741,
            "title": "Discussion"
        },
        {
            "endOffset": 26127,
            "parents": [
                {
                    "id": "s0025",
                    "title": "Results"
                }
            ],
            "secId": "s0035",
            "sentence": "The average effectiveness is predicted to be low because Eq. (4) estimates that both CVVs are 2 \u00b1 13% effective against the A/Arizona/36/2018 and A/Paris/2511/2018 clusters.",
            "startOffset": 25954,
            "title": "Prediction of effectiveness for the 2018/19 A(H3N2) vaccines"
        },
        {
            "endOffset": 17448,
            "parents": [],
            "secId": "s0005",
            "sentence": "Epitopes are modules of amino acids to which the antibody receptor binds.",
            "startOffset": 17375,
            "title": "Introduction"
        },
        {
            "endOffset": 17980,
            "parents": [],
            "refoffsets": {
                "b0025": {
                    "endOffset": 17979,
                    "startOffset": 17976
                }
            },
            "secId": "s0005",
            "sentence": "These viral quasispecies are clusters of variants that have evolved with similar mutations to be sufficiently distant from the vaccine strain such that they are expected to evade antibody recognition [5].",
            "startOffset": 17776,
            "title": "Introduction"
        },
        {
            "endOffset": 21255,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0065": {
                    "endOffset": 21254,
                    "startOffset": 21250
                }
            },
            "secId": "s0015",
            "sentence": "We created a pEpitope Calculator application for MATLAB that can be downloaded [13].",
            "startOffset": 21171,
            "title": "Antigenic analysis of circulating A(H3N2) influenza viruses, 2017/18 and 2018/19"
        },
        {
            "endOffset": 31006,
            "parents": [],
            "secId": "s0050",
            "sentence": "The pEpitope model can check that the viruses that have been isolated and reassorted with high growth properties by vaccine producers continue to maintain their key antigenic features.",
            "startOffset": 30822,
            "title": "Conclusions"
        },
        {
            "endOffset": 28357,
            "parents": [],
            "refoffsets": {
                "b0005": {
                    "endOffset": 28356,
                    "startOffset": 28353
                }
            },
            "secId": "s0040",
            "sentence": "Several recent studies have identified specific amino acid substitutions that have been key to many past substantial antigenic changes [1].",
            "startOffset": 28218,
            "title": "Discussion"
        },
        {
            "endOffset": 32987,
            "parents": [],
            "secId": "s0060",
            "sentence": "MEB and MWD revised and edited the manuscript.",
            "startOffset": 32941,
            "title": "Author contributions"
        },
        {
            "endOffset": 28879,
            "parents": [],
            "refoffsets": {
                "b0035": {
                    "endOffset": 28816,
                    "startOffset": 28813
                },
                "b0100": {
                    "endOffset": 28786,
                    "startOffset": 28782
                }
            },
            "secId": "s0040",
            "sentence": "For instance, low vaccine effectiveness during the 2016/17 season was suggested to have resulted from an egg-adapted substitution at site 160 in epitope B, which was identified both by biochemical analysis [20] and by the pEpitope model [7], but was not previously identified as a key substitution site.",
            "startOffset": 28576,
            "title": "Discussion"
        },
        {
            "endOffset": 25641,
            "parents": [
                {
                    "id": "s0025",
                    "title": "Results"
                }
            ],
            "secId": "s0035",
            "sentence": "On average against all circulating strains during the 2017/18 season, the egg-based CVV has a 0.121 pepitope distance, and Eq. (4) predicts the vaccine effectiveness to be 25 \u00b1 11%.",
            "startOffset": 25460,
            "title": "Prediction of effectiveness for the 2018/19 A(H3N2) vaccines"
        },
        {
            "endOffset": 32883,
            "parents": [],
            "secId": "s0060",
            "sentence": "MEB and MWD designed the pEpitope Calculator app.",
            "startOffset": 32834,
            "title": "Author contributions"
        },
        {
            "endOffset": 26740,
            "parents": [],
            "secId": "s0040",
            "sentence": "Analysis of all circulating strains in pepitope-distance space predicted that both the egg- and cell-based CVVs will have positive effectiveness against the majority of strains during the 2018/19 season.",
            "startOffset": 26537,
            "title": "Discussion"
        },
        {
            "endOffset": 20721,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "For the early 2018/19 season, we utilized 83 strains collected in June 2018, 56 in July, 42 in August, 49 in September, 49 in October, 50 in November, and 8 strains in December, for a total of 337 strains.",
            "startOffset": 20516,
            "title": "Antigenic analysis of circulating A(H3N2) influenza viruses, 2017/18 and 2018/19"
        },
        {
            "endOffset": 20515,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "After removing passaged and incomplete strains, we utilized 374 strains collected in September 2017, 560 in October, 700 in November 1001 in December 1064 strains collected in January 2018, 549 in February, 381 in March, 141 in April, and 31 in May, for a total of 4801 strains in the 2017/18 season.",
            "startOffset": 20215,
            "title": "Antigenic analysis of circulating A(H3N2) influenza viruses, 2017/18 and 2018/19"
        },
        {
            "endOffset": 18544,
            "parents": [],
            "secId": "s0005",
            "sentence": "Producing an effective vaccine against this rapidly evolving virus necessitates a comprehensive method to characterize the antigenic distance sensitivity in humans.",
            "startOffset": 18380,
            "title": "Introduction"
        },
        {
            "endOffset": 28575,
            "parents": [],
            "secId": "s0040",
            "sentence": "However, we believe the comprehensive approach presented here that considers all of the antigenic sites is important to detect future antigenic drift and substantial antigenic changes during the manufacturing process.",
            "startOffset": 28358,
            "title": "Discussion"
        },
        {
            "endOffset": 30093,
            "parents": [],
            "secId": "s0045",
            "sentence": "Future work will incorporate analyses of the A(H1N1), B/Yamagata/16/88 lineage, and B/Victoria/2/87 lineage vaccine components to produce a complete model of influenza vaccine effectiveness.",
            "startOffset": 29903,
            "title": "Limitations"
        },
        {
            "endOffset": 32505,
            "parents": [],
            "secId": "s0105",
            "sentence": "This A/Kansas/14/2017 specimen (EPI1146345) is identical in the HA region to A/Arizona/36/2018 (EPI1256668), which was the representative strain of the emerging quasispecies identified by our pEpitope model.",
            "startOffset": 32298,
            "title": "Note added in proof"
        },
        {
            "endOffset": 27529,
            "parents": [],
            "secId": "s0040",
            "sentence": "These predictions are based on the pEpitope model being able to explain much of the variance in vaccine effectiveness data from humans in recent studies conducted by the US Flu VE Network, over the past 47 years, and over the past decade.",
            "startOffset": 27291,
            "title": "Discussion"
        },
        {
            "endOffset": 24173,
            "parents": [
                {
                    "id": "s0025",
                    "title": "Results"
                }
            ],
            "secId": "s0030",
            "sentence": "Multidimensional scaling of the early 2018/19 strains again revealed a broad cluster and a smaller, relatively distant one (Fig. 2B).",
            "startOffset": 24040,
            "title": "Emergence of an A(H3N2) quasispecies during the 2018/19 season"
        },
        {
            "endOffset": 20214,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "refoffsets": {
                "b0060": {
                    "endOffset": 20136,
                    "startOffset": 20132
                }
            },
            "secId": "s0015",
            "sentence": "We obtained HA sequences from the Global Initiative on Sharing All Influenza Data (GISAID) EpiFlu\u2122 database [12] for all A(H3N2) strains circulating between September 2017 and December 2018.",
            "startOffset": 20024,
            "title": "Antigenic analysis of circulating A(H3N2) influenza viruses, 2017/18 and 2018/19"
        },
        {
            "endOffset": 21447,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Multidimensional scaling was performed using the MATLAB Statistics and Machine Learning Toolbox\u2122, and the pepitope-distance spaces for 2017/18 and 2018/19 were each reduced to two dimensions.",
            "startOffset": 21256,
            "title": "Antigenic analysis of circulating A(H3N2) influenza viruses, 2017/18 and 2018/19"
        },
        {
            "endOffset": 31780,
            "parents": [],
            "secId": "s0050",
            "sentence": "There are slight antigenic differences between these CVVs that may match up to strains dominating in particular geographical regions.",
            "startOffset": 31647,
            "title": "Conclusions"
        },
        {
            "endOffset": 30272,
            "parents": [],
            "secId": "s0050",
            "sentence": "These results suggest that the pEpitope model is useful to several aspects of virological characterization for design and manufacture of the A(H3N2) vaccine component.",
            "startOffset": 30105,
            "title": "Conclusions"
        },
        {
            "endOffset": 32797,
            "parents": [],
            "secId": "s0060",
            "sentence": "MEB and RYK analyzed data.",
            "startOffset": 32771,
            "title": "Author contributions"
        },
        {
            "endOffset": 27972,
            "parents": [],
            "secId": "s0040",
            "sentence": "Therefore, epidemiological data from the past decade were expected to benefit from these improvements in the field, and the pEpitope model demonstrated a greater coefficient of determination over the past decade as compared to over the past 47 years.",
            "startOffset": 27722,
            "title": "Discussion"
        },
        {
            "endOffset": 18379,
            "parents": [],
            "secId": "s0005",
            "sentence": "The human immune system can tolerate small antigenic distances between the influenza vaccine and infecting virus strains, however quasispecies that emerge at larger distances from the vaccine will not be successfully recognized by primed antibodies.",
            "startOffset": 18130,
            "title": "Introduction"
        },
        {
            "endOffset": 32940,
            "parents": [],
            "secId": "s0060",
            "sentence": "MEB and RYK developed the first draft of the manuscript.",
            "startOffset": 32884,
            "title": "Author contributions"
        },
        {
            "endOffset": 32297,
            "parents": [],
            "secId": "s0105",
            "sentence": "While this paper was in review, the CDC released an addendum to the recommended composition of influenza virus vaccines for use in the 2019/20 northern hemisphere influenza season (https://www.who.int/influenza/vaccines/virus/recommendations/201902_recommendation_addendum.pdf), announcing an A/Kansas/14/2017-like virus as the A(H3N2) component.",
            "startOffset": 31951,
            "title": "Note added in proof"
        },
        {
            "endOffset": 25732,
            "parents": [
                {
                    "id": "s0025",
                    "title": "Results"
                }
            ],
            "secId": "s0035",
            "sentence": "The cell-based CVV, with a 0.111 pepitope distance, is predicted to be 29 \u00b1 10% effective.",
            "startOffset": 25642,
            "title": "Prediction of effectiveness for the 2018/19 A(H3N2) vaccines"
        },
        {
            "endOffset": 20983,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "We additionally obtained HA sequences for the two candidate vaccine viruses (CVV) that the World Health Organization (WHO) recommended for the 2018/19 northern hemisphere season, egg-based A/Singapore/INFIMH-16-0019/2016 and cell-based A/North Carolina/04/2016.",
            "startOffset": 20722,
            "title": "Antigenic analysis of circulating A(H3N2) influenza viruses, 2017/18 and 2018/19"
        },
        {
            "endOffset": 23744,
            "parents": [
                {
                    "id": "s0025",
                    "title": "Results"
                }
            ],
            "secId": "s0030",
            "sentence": "Multidimensional scaling of the 2017/18 circulating strains revealed one large cluster, with two centroids, near the WHO-recommended 2018/19 CVVs and a smaller, comparatively distant cluster (Fig. 2A).",
            "startOffset": 23543,
            "title": "Emergence of an A(H3N2) quasispecies during the 2018/19 season"
        },
        {
            "endOffset": 21170,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "The antigenic distance was calculated between all pairs of strains by determining the number of amino acid differences in each epitope, and taking the maximum pk to be pepitope (Eq. (1)).",
            "startOffset": 20983,
            "title": "Antigenic analysis of circulating A(H3N2) influenza viruses, 2017/18 and 2018/19"
        },
        {
            "endOffset": 29413,
            "parents": [],
            "refoffsets": {
                "b0110": {
                    "endOffset": 29310,
                    "startOffset": 29306
                }
            },
            "secId": "s0045",
            "sentence": "Additionally, structural studies of the influenza HA glycosylation state have shown that glycans can shield the surrounding amino acids [22], thereby potentially inhibiting antibody recognition further than do individual amino acid mismatches.",
            "startOffset": 29170,
            "title": "Limitations"
        },
        {
            "endOffset": 24400,
            "parents": [
                {
                    "id": "s0025",
                    "title": "Results"
                }
            ],
            "secId": "s0030",
            "sentence": "This A/Paris/2511/2018 cluster contains 36 strains, or 10.7% of those circulating in early 2018/19.",
            "startOffset": 24301,
            "title": "Emergence of an A(H3N2) quasispecies during the 2018/19 season"
        },
        {
            "endOffset": 31932,
            "parents": [],
            "secId": "s0050",
            "sentence": "Several vaccine choices can be rapidly analyzed against thousands of strains circulating in a particular region to help make these localized decisions.",
            "startOffset": 31781,
            "title": "Conclusions"
        }
    ],
    "docId": "S0264410X19304177",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": "meb16@rice.edu",
                "first": "Melia E.",
                "initial": "M.E.",
                "last": "Bonomo"
            },
            {
                "email": "ryk4@rice.edu",
                "first": "Rachel Y.",
                "initial": "R.Y.",
                "last": "Kim"
            },
            {
                "email": "mwdeem@rice.edu",
                "first": "Michael W.",
                "initial": "M.W.",
                "last": "Deem"
            }
        ],
        "doi": "10.1016/j.vaccine.2019.03.068",
        "firstpage": "3154",
        "issn": "0264410X",
        "keywords": [
            "Antigenic distance",
            "Immunity",
            "Mathematical models",
            "Seasonal influenza",
            "Vaccination planning",
            "Vaccine effectiveness"
        ],
        "lastpage": "3158",
        "openaccess": "Full",
        "pub_year": 2019,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "Modular epitope binding predicts influenza quasispecies dominance and vaccine effectiveness: Application to 2018/19 season"
    }
}